Invesco Pharmaceuticals ETF

PJP is a US Equities ETF. The Invesco Dynamic Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

PJP tracks the Dynamic Pharmaceuticals Intellidex Index.

No, PJP is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, PJP is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on PJP is -0.0487%. This is the percent change in the value of PJP over the most recent 1-month period. The 3-month return on PJP is -0.0177%. This is the percent change in the value of PJP over the most recent 3-month period.

The standard deviation of PJP for the past year is 0.1532%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to PJP include XLI, XLY, and XLE.

ETFs correlated to PJP include VHT, FHLC, and IYH.

ETFs that are inversely correlated to PJP include SDOW, DXD, and DOG.